MedAI Verdict
All comparisons

Glass Health vs Sepsis ImmunoScore

A hospital sepsis program evaluates Prenosis. Sepsis ImmunoScore holds FDA De Novo DEN230036, decision date April 2024. It sorts adults with suspected sepsis in the ED or hospital into four risk bands from up to 22 EHR parameters, and the vendor says it is not validated in the ICU or on labor and delivery units. Pricing is by demo or contact only. Its papers include a vendor-run development and validation study in NEJM AI and further vendor-listed papers in Diagnostics and JAMIA Open. A hospital sepsis program and an individual physician do not shop for the same tool.

An individual physician evaluates Glass Health, an ambient scribe with cited differentials and must-not-miss flags. The vendor claims no FDA status. A 2024 paper in The Neurologist ran four NEJM cases through Glass, and the tool got 1 right while ChatGPT-4 got 0 and a diagnostic generator got all four. The comparison was tiny and non-randomized.

Decision support · Reviewed November 2, 2026

Glass Health logo

Glass Health

by Glass Health · founded 2021

DDx plus literature-grounded A&P plus ambient scribe in one workflow.

AI sepsis risk score from up to 22 EHR parameters for adults with suspected sepsis in the ED or hospital, FDA De Novo authorized.

When to pick each one

Glass Health

  • Differential diagnosis with must-not-miss flags
  • Four-case NEJM test, 1 correct versus 0 for ChatGPT-4
Read the full Glass Health review

Sepsis ImmunoScore

  • FDA De Novo DEN230036, April 2024
  • Sepsis score for adults in the ED or hospital
Read the full Sepsis ImmunoScore review

Score

Each row shows points earned of points available under the published rubric.

Glass Health

42of 100

Competitive

Sepsis ImmunoScore

37of 100

Competitive
Score by dimension for Glass Health and Sepsis ImmunoScore
DimensionGlass HealthSepsis ImmunoScoreDifference
FDA clearance0 / 1212 / 12-12
HIPAA / SOC2 / BAA6 / 100 / 10+6
EHR integrations (count)2.8 / 5.60 / 5.6+2.8
Top-3 EHR coverage (Epic / Oracle / Athena)3.4 / 4.80 / 4.8+3.4
Bidirectional write-back0 / 1.20 / 1.20
Peer-reviewed papers8.4 / 2114.7 / 21-6.3
RCT / meta-analysis / systematic review0 / 90 / 90
Funding & adoption signal8.4 / 123 / 12+5.4
Pricing transparency2.5 / 2.51.3 / 2.5+1.3
Years in market4.2 / 60 / 6+4.2

Scroll horizontally to see every column.

How scores are computed

Pricing

Glass Health

TierMonthlyAnnualNotes
Liten/an/aLimited scribing and clinical decision support. Carries ad sponsorships.
Starter$20n/aCarries ad sponsorships.
Pro$90n/aMost popular tier, ad-free.
Max$200n/aFor clinics. EHR integration (Athena, Epic, eCW, Elation) is available only on this tier.

Sepsis ImmunoScore

TierMonthlyAnnualNotes
Enterprisen/an/aNo public price. Demo or contact only.

Evidence

Glass Health

FDA decisions

No FDA decision cited in our research as of October 26, 2026.

Peer-reviewed

1 PubMed record names Glass Health.

Community

1 post sourced: 0 positive, 1 neutral, 0 negative.

Compliance and integrations

Documented from each vendor’s own pages.

SpecGlass HealthSepsis ImmunoScore
Free tierYesNo / unverified
HIPAANo / unverifiedNo / unverified
SOC 2 Type IINo / unverifiedNo / unverified
EHR integrationsEpic, athenahealth, eClinicalWorks, ElationNot specified
Founded2021n/a
HQUSUS

Scroll horizontally to see both columns.

Common questions

Open the full decision support comparison

Differential diagnosis, treatment guidance, drug interactions, evidence-grounded Q&A. The CDS landscape ranges from the UpToDate gold standard to physician-only OpenEvidence. We compared what clinicians actually use.